Pasithea Therapeutics Corp.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $15,979,361.
Profit Margin
| 2020 | 0 | -40.98K | |
|---|---|---|---|
| 2021 | 15.06K | -2.17M | -14433.87% |
| 2022 | 486.55K | -13.05M | -2683.43% |
| 2023 | 0 | -15.96M |
KTTA Income Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 486.55K | 15.06K | 0 |
Cost of revenue | 648.45K | 113.19K | 17.27K | 0 |
Gross profit | -648.45K | 373.36K | -2.21K | 0 |
Operating exp. | ||||
Research and development | 8.10M | 2.66M | 0 | 0 |
Selling and marketing | -7.87B | 2.60M | 0 | 0 |
Total operating expenses | 15.97M | 15.18M | 4.50M | 40.98K |
Operating income | -15.97M | -14.81M | -4.50M | -40.98K |
Other income (expenses), net | 471.61K | 879.86K | 2.33M | -4 |
Income before tax | -15.50M | -13.93M | -2.17M | -40.98K |
Income tax expense | 0 | -879.97K | 508 | -61.47K |
Net income | -15.96M | -13.05M | -2.17M | -40.98K |
Earnings per share | ||||
Basic EPS | -12.65 | -10.34 | -1.89 | -0.05 |
Diluted EPS | -13.01 | -10.34 | -1.89 | -0.05 |
| Data source | Data source | Data source |